Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
GILEAD SCIENCES, INC. | EVP,Corp Affairs & Gen Counsel | Common Stock | 33.4K | $2.87M | $85.78 | Jun 10, 2022 | Direct |
CYTOKINETICS INC | EVP, Chief Legal Officer | Common Stock | 33.1K | $1.9M | $57.26 | Aug 30, 2024 | Direct |
GILEAD SCIENCES, INC. | EVP,Corp Affairs & Gen Counsel | Restricted Stock Unit | 16.5K | $1.31M | $79.02 | Jun 10, 2022 | Direct |
CYTOKINETICS INC | EVP, Chief Legal Officer | Non-Qualified Stock Option (Right to Buy) | 51K | Aug 30, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CYTK | CYTOKINETICS INC | Aug 30, 2024 | 2 | $0 | 4 | Sep 3, 2024 | EVP, Chief Legal Officer |
CYTK | CYTOKINETICS INC | Aug 13, 2024 | 0 | $0 | 3/A | Aug 19, 2024 | EVP, Chief Legal Officer |
GILD | GILEAD SCIENCES, INC. | Jun 10, 2022 | 3 | -$17K | 4 | Jun 13, 2022 | EVP,Corp Affairs & Gen Counsel |
GILD | GILEAD SCIENCES, INC. | Mar 10, 2022 | 6 | -$333K | 4 | Mar 14, 2022 | EVP,Corp Affairs & Gen Counsel |
GILD | GILEAD SCIENCES, INC. | Feb 15, 2022 | 1 | $18.1K | 4 | Apr 13, 2022 | EVP,Corp Affairs & Gen Counsel |
GILD | GILEAD SCIENCES INC | Feb 9, 2022 | 1 | -$108K | 4 | Feb 11, 2022 | EVP,Corp Affairs & Gen Counsel |
GILD | GILEAD SCIENCES INC | Feb 6, 2022 | 3 | -$66.2K | 4 | Feb 8, 2022 | EVP,Corp Affairs & Gen Counsel |
GILD | GILEAD SCIENCES INC | Feb 1, 2022 | 1 | -$964K | 4 | Feb 2, 2022 | EVP,Corp Affairs & Gen Counsel |
GILD | GILEAD SCIENCES INC | Jan 26, 2022 | 3 | -$383K | 4 | Jan 28, 2022 | EVP,Corp Affairs & Gen Counsel |
GILD | GILEAD SCIENCES INC | Aug 15, 2021 | 1 | $1.76K | 4 | Aug 24, 2021 | EVP,Corp Affairs & Gen Counsel |